查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586173

细胞分析市场：按产品、流程和最终用户划分 - 全球预测 2025-2030

Cell Analysis Market by Product (Cell Counters, Cell Microarrays, Flow Cytometry Products), Process (Cell Counting & Quality Control, Cell Identification, Cell Interaction), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年细胞分析市值为221.4亿美元，预计2024年将达到242.5亿美元，复合年增长率为9.58%，到2030年将达到420.3亿美元。

细胞分析是生命科学中的关键过程，也是研究、诊断和治疗开发的基石。它涉及检查细胞以深入了解它们的功能、特性和相互作用。细胞分析的需求源自于疾病理解、药物开发和个人化医疗进步的应用。其应用范围广泛，包括药物发现、癌症研究和干细胞研究，最终用途主要是医疗机构、研究机构和生物技术公司。市场成长的主要驱动力是高通量筛检和单细胞分析技术等技术进步、慢性病盛行率上升以及政府支持细胞研究的措施。开发自动化和人工智慧驱动的细胞分析仪器的机会比比皆是，这有望提高效率和准确性。此外，新型再生医学和免疫治疗研究中越来越多地采用细胞分析，预计将显着增长。然而，先进细胞分析系统的高成本、样品製备的复杂性以及某些细胞疗法的伦理问题等挑战可能会阻碍市场扩张。另一个阻碍因素是这些技术产生的大量资料的资料管理问题。应对这些挑战需要技术创新，重点是开发具有成本效益的解决方案、简化流程和增强资料分析能力。最有前景的创新领域包括整合机器学习演算法以改进预测分析以及分析工具的小型化以促进实验室晶片解决方案。这些创新可以大大提高各种最终使用环境中的扩充性和可访问性。市场充满活力且竞争激烈，企业有机会透过产品差异化和附加价值服务来实现差异化。随着竞争格局的不断发展，透过采取跨学科方法和促进合作来保持领先地位对于维持成长和在市场格局中保持竞争力至关重要。

主要市场统计
基准年[2023] 221.4亿美元
预测年份 [2024] 242.5亿美元
预测年份 [2030] 420.3亿美元
复合年增长率（%） 9.58%

市场动态：揭示快速发展的细胞分析市场的关键市场洞察

细胞分析市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 慢性病及感染疾病率增加
    • 介绍技术先进的产品和诊断实验室
    • 政府对生命科学的投资以及生物製药和生物技术产业的快速扩张
  • 市场限制因素
    • 缺乏熟练的专业人员
  • 市场机会
    • 研究开发和新产品开发的合作活动
    • 细胞分析在个人化医疗的应用
  • 市场挑战
    • 复杂且耗时的监管指南

波特的五力：驾驭细胞分析市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解细胞分析市场的外部影响

外部宏观环境因素在塑造细胞分析市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解细胞分析市场的竞争状况

细胞分析市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵细胞分析市场供应商绩效评估

FPNV定位矩阵是评估细胞分析市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了细胞分析市场的成功之路

细胞分析市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和感染疾病的发生率增加
      • 介绍技术先进的产品和诊断实验室
      • 政府对生命科学的投资以及生物製药和生物技术产业的快速扩张
    • 抑制因素
      • 缺乏熟练的专业人员
    • 机会
      • 研究开发和新产品开发的合作活动
      • 细胞分析在个人化医疗的应用
    • 任务
      • 复杂且耗时的监管指南
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章细胞分析市场：副产品

  • 细胞计数器
  • 细胞微阵列
  • 流式细胞技术产品
  • 高内涵筛检系统
  • 显微镜
  • 定量PCR产品
  • 光强度

第七章细胞分析市场：依流程

  • 细胞计数和品管
  • 细胞识别
  • 细胞交互作用
  • 细胞增殖
  • 细胞讯号传导途径或讯号传导
  • 细胞结构研究
  • 细胞活力
  • 单细胞分析
  • 目标识别与检验

第 8 章 细胞分析市场：依最终使用者分类

  • 细胞培养物保藏库
  • 合约调查机构
  • 医院和诊断实验室
  • 製药和生物技术公司
  • 调查机构

第九章北美和南美细胞分析市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太细胞分析市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲细胞分析市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • BioStatus Limited
  • Carl Zeiss AG
  • Cell Biolabs, Inc.
  • Creative Bioarray
  • Cytek Biosciences
  • Danaher Corporation
  • EVIDENT
  • GE Healthcare
  • Meiji Techno
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • Nanocellect Biomedical
  • PerkinElmer Inc.
  • Promega Corporation
  • Sysmex America, Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific
Product Code: MRR-431F213C90BB

The Cell Analysis Market was valued at USD 22.14 billion in 2023, expected to reach USD 24.25 billion in 2024, and is projected to grow at a CAGR of 9.58%, to USD 42.03 billion by 2030.

Cell analysis is a critical process in life sciences, serving as a cornerstone in research, diagnostics, and therapeutic developments. It involves examining cells for insights into their functions, characteristics, and interactions. The necessity of cell analysis stems from its applications in understanding diseases, developing drugs, and advancing personalized medicine. Its applications are broad, including drug discovery, cancer research, and stem cell research, with end-use predominant in healthcare institutions, research organizations, and biotechnology firms. Market growth is primarily driven by technological advancements such as high-throughput screening and single-cell analysis technologies, rising prevalence of chronic disorders, and government initiatives supporting cell-based research. Opportunities abound in the development of automated and AI-driven cell analysis instruments, which promise increased efficiency and precision. Moreover, expanding adoption of cell analysis in novel regenerative medicine and immunotherapy research presents significant growth prospects. However, challenges such as high costs of advanced cell analysis systems, complexities in sample preparation, and ethical concerns regarding certain cell therapies may hinder market expansion. Limitations also include data management issues due to the vast amount of data generated by these technologies. To combat these challenges, emphasis on innovation could focus on developing cost-effective solutions, simplifying processes, and enhancing data analytics capabilities. The most promising areas for innovation include integrating machine learning algorithms to improve predictive analytics and the miniaturization of analysis tools to promote lab-on-a-chip solutions. These innovations can significantly enhance scalability and accessibility in various end-use environments. The market is dynamic and highly competitive, with opportunities for companies to differentiate themselves through product differentiation and value-added services. As the landscape continues to evolve, staying ahead by embracing cross-disciplinary approaches and fostering collaborations will be essential for sustaining growth and maintaining a competitive edge in the cell analysis market.

KEY MARKET STATISTICS
Base Year [2023] USD 22.14 billion
Estimated Year [2024] USD 24.25 billion
Forecast Year [2030] USD 42.03 billion
CAGR (%) 9.58%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Analysis Market

The Cell Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of chronic and infectious diseases
    • Introduction of technologically advanced products and diagnostic laboratories
    • Government investments in life sciences sector and rapid expansion of the biopharmaceutical & biotechnological industry
  • Market Restraints
    • Limited availability of skilled professionals
  • Market Opportunities
    • Collaboration activities for R&D and new product development
    • Applications of cell analysis in personalized medicine
  • Market Challenges
    • Complex & time-consuming regulatory guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Cell Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Analysis Market

A detailed market share analysis in the Cell Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Analysis Market

A strategic analysis of the Cell Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Analysis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., BioStatus Limited, Carl Zeiss AG, Cell Biolabs, Inc., Creative Bioarray, Cytek Biosciences, Danaher Corporation, EVIDENT, GE Healthcare, Meiji Techno, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Nanocellect Biomedical, PerkinElmer Inc., Promega Corporation, Sysmex America, Inc., Tecan Trading AG, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Cell Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cell Counters, Cell Microarrays, Flow Cytometry Products, High-Content Screening Systems, Microscopes, QPCR Products, and Spectrophotometers.
  • Based on Process, market is studied across Cell Counting & Quality Control, Cell Identification, Cell Interaction, Cell Proliferation, Cell Signaling Pathway or Signal Transduction, Cell Structure Study, Cell Viability, Single-Cell Analysis, and Target Identification & Validation.
  • Based on End-User, market is studied across Cell Culture Collection Repositories, Contract Research Organizations, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic and infectious diseases
      • 5.1.1.2. Introduction of technologically advanced products and diagnostic laboratories
      • 5.1.1.3. Government investments in life sciences sector and rapid expansion of the biopharmaceutical & biotechnological industry
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaboration activities for R&D and new product development
      • 5.1.3.2. Applications of cell analysis in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Complex & time-consuming regulatory guidelines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Analysis Market, by Product

  • 6.1. Introduction
  • 6.2. Cell Counters
  • 6.3. Cell Microarrays
  • 6.4. Flow Cytometry Products
  • 6.5. High-Content Screening Systems
  • 6.6. Microscopes
  • 6.7. QPCR Products
  • 6.8. Spectrophotometers

7. Cell Analysis Market, by Process

  • 7.1. Introduction
  • 7.2. Cell Counting & Quality Control
  • 7.3. Cell Identification
  • 7.4. Cell Interaction
  • 7.5. Cell Proliferation
  • 7.6. Cell Signaling Pathway or Signal Transduction
  • 7.7. Cell Structure Study
  • 7.8. Cell Viability
  • 7.9. Single-Cell Analysis
  • 7.10. Target Identification & Validation

8. Cell Analysis Market, by End-User

  • 8.1. Introduction
  • 8.2. Cell Culture Collection Repositories
  • 8.3. Contract Research Organizations
  • 8.4. Hospitals & Diagnostic Laboratories
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Research Institutes

9. Americas Cell Analysis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Analysis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Analysis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies Inc.
  • 2. Becton, Dickinson and Company
  • 3. Bio-Rad Laboratories Inc.
  • 4. BioStatus Limited
  • 5. Carl Zeiss AG
  • 6. Cell Biolabs, Inc.
  • 7. Creative Bioarray
  • 8. Cytek Biosciences
  • 9. Danaher Corporation
  • 10. EVIDENT
  • 11. GE Healthcare
  • 12. Meiji Techno
  • 13. Merck KGaA
  • 14. Miltenyi Biotec B.V. & Co. KG
  • 15. Nanocellect Biomedical
  • 16. PerkinElmer Inc.
  • 17. Promega Corporation
  • 18. Sysmex America, Inc.
  • 19. Tecan Trading AG
  • 20. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. CELL ANALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. CELL ANALYSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL ANALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL ANALYSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL ANALYSIS MARKET SIZE, BY FLOW CYTOMETRY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL ANALYSIS MARKET SIZE, BY HIGH-CONTENT SCREENING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL ANALYSIS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL ANALYSIS MARKET SIZE, BY QPCR PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL ANALYSIS MARKET SIZE, BY SPECTROPHOTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL COUNTING & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL INTERACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL PROLIFERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL SIGNALING PATHWAY OR SIGNAL TRANSDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL STRUCTURE STUDY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL VIABILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL ANALYSIS MARKET SIZE, BY SINGLE-CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL ANALYSIS MARKET SIZE, BY TARGET IDENTIFICATION & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL CULTURE COLLECTION REPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CELL ANALYSIS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CELL ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CELL ANALYSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. SINGAPORE CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. TAIWAN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. TAIWAN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 84. TAIWAN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. THAILAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. THAILAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 87. THAILAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. VIETNAM CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. VIETNAM CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 90. VIETNAM CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 95. DENMARK CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. DENMARK CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 97. DENMARK CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. EGYPT CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. EGYPT CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 100. EGYPT CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. FINLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. FINLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 103. FINLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. FRANCE CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. FRANCE CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 106. FRANCE CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. GERMANY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. GERMANY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 109. GERMANY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. ISRAEL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. ISRAEL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 112. ISRAEL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. ITALY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. ITALY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 115. ITALY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 118. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. NIGERIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. NIGERIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 121. NIGERIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. NORWAY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. NORWAY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 124. NORWAY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. POLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. POLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 127. POLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. QATAR CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. QATAR CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 130. QATAR CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. RUSSIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. RUSSIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 133. RUSSIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 136. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SPAIN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SPAIN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 142. SPAIN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. SWEDEN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SWEDEN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 145. SWEDEN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 148. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TURKEY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. TURKEY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 151. TURKEY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 159. CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023